Mediator Complex Subunit 17 (MED17) Activators encompass a range of chemical compounds that indirectly enhance its functional activity within the transcriptional Mediator complex through several distinct signaling pathways. For instance, TNF-α, by activating the NF-κB pathway, indirectly boosts the expression of genes encoding Mediator complex subunits, thereby enhancing the functional activity of MED17. Similarly, PMA activates PKC, which leads to activation of transcription factors requiring the Mediator complex, thus increasing MED17's role in transcription. EGF and Insulin, via the MAPK/ERK and PI3K/Akt pathways respectively, amplify transcription factor activity, which necessitates the involvement of MED17. Lithium chloride, through GSK-3 inhibition, and Retinoic acid, by modulating gene expression via nuclear receptors, both necessitate the recruitment of the Mediator complex, including MED17. Forskolin's action on cAMP andPKA further underscores MED17's significance in transcriptional regulation. Additionally, chromatin-modifying agents like Trichostatin A and 5-Azacytidine, by influencing chromatin accessibility and DNA methylation, respectively, heighten the requirement for the Mediator complex in transcription, indirectly enhancing MED17 activity.
The biochemical activation mechanisms of MED17 also involve histone acetylation and hormonal signaling pathways. Sodium butyrate, another histone deacetylase inhibitor, facilitates an open chromatin configuration conducive for transcription, thereby indirectly promoting MED17 activity as part of the Mediator complex. Hormone-like molecules such as β-estradiol and Dexamethasone function by binding to specific receptors that interact with the Mediator complex to modulate gene transcription, consequentially increasing the functional demand for MED17. These various chemical activators, though diverse in their primary targets and pathways, ultimately converge on the transcriptional machinery that MED17 is integral to, ensuring its functional enhancement without directly affecting its transcription or translation. Through these multifaceted biochemical interactions, each of these compounds plays a role in augmenting the activity of MED17, underlining their importance in the complex regulation of gene expression.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC) which can lead to the activation of transcription factors that work in conjunction with the Mediator complex. Hence, PMA indirectly enhances the functional activity of MED17 by stimulating transcription pathways that require Mediator function. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin signaling can activate various transcription factors through the PI3K/Akt pathway, which can enhance the transcription of genes and require the Mediator complex for their expression. MED17, being a part of this complex, would therefore have an increased functional role. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium inhibits glycogen synthase kinase 3 (GSK-3), which can lead to the activation of Wnt signaling pathway target genes. This requires the recruitment of the Mediator complex, thereby increasing the functional demand for MED17. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate, a histone deacetylase inhibitor, can enhance chromatin accessibility and gene expression, thus increasing the requirement for the Mediator complex in transcription processes, indirectly enhancing MED17 activity. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
β-estradiol binds to estrogen receptors, which interact with the Mediator complex to regulate gene expression. This interaction can indirectly enhance MED17 activity by increasing the demand for Mediator complex in transcription. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone binds to glucocorticoid receptors, which then interact with the Mediator complex, including MED17, to regulate gene transcription, indirectly enhancing the activity of MED17. | ||||||